Tower Research Capital LLC (Trc) Corbus Pharmaceuticals Holdings, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.11 - $5.46 $5,406 - $268,375	49,153 Added 664.68%	56,548 $6,000
Q3 2022 Nov 10, 2022	BUY	$0.17 - $5.31 $1,257 - $39,267	7,395 New	7,395 $1,000
Q2 2022 Aug 15, 2022	SELL	$0.21 - $0.53 $1,908 - $4,815	-9,086 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$0.32 - $0.67 $2,086 - $4,369	6,521 Added 254.23%	9,086 $5,000
Q4 2021 Feb 14, 2022	BUY	$0.6 - $1.11 $1,479 - $2,736	2,465 Added 2465.0%	2,565 $2,000
Q3 2021 Nov 15, 2021	SELL	$1.01 - $1.82 $17,060 - $30,743	-16,892 Reduced 99.41%	100 $0
Q2 2021 Aug 16, 2021	SELL	$1.39 - $2.21 $73,800 - $117,337	-53,094 Reduced 75.76%	16,992 $31,000
Q1 2021 May 17, 2021	BUY	$1.27 - $3.42 $50,165 - $135,090	39,500 Added 129.14%	70,086 $138,000
Q4 2020 Feb 16, 2021	SELL	$0.94 - $1.89 $82,943 - $166,769	-88,238 Reduced 74.26%	30,586 $38,000
Q3 2020 Nov 16, 2020	BUY	$1.5 - $9.38 $141,661 - $885,856	94,441 Added 387.32%	118,824 $214,000
Q2 2020 Aug 13, 2020	BUY	$4.79 - $8.39 $116,794 - $204,573	24,383 New	24,383 $205,000
Q1 2020 May 15, 2020	SELL	$3.44 - $7.21 $1,376 - $2,884	-400 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$4.29 - $5.64 $15,478 - $20,349	-3,608 Reduced 90.02%	400 $2,000
Q3 2019 Nov 05, 2019	BUY	$4.87 - $7.08 $19,031 - $27,668	3,908 Added 3908.0%	4,008 $20,000
Q2 2019 Aug 13, 2019	BUY	$6.6 - $7.8 $660 - $780	100 New	100 $1,000
Q3 2018 Nov 13, 2018	SELL	$4.65 - $7.95 $22,585 - $38,613	-4,857 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$5.05 - $6.8 $24,527 - $33,027	4,857 New	4,857 $25,000
Q1 2018 May 15, 2018	SELL	$5.6 - $9.25 $6,557 - $10,831	-1,171 Closed	0 $0
Q4 2017 Feb 09, 2018	SELL	$6.6 - $7.78 $6,553 - $7,725	-993 Reduced 45.89%	1,171 $8,000
Q3 2017 Nov 14, 2017	BUY	$5.75 - $7.75 $12,443 - $16,771	2,164	2,164 $16,000

Others Institutions Holding CRBP

# of Institutions

Shares Held

38.7K

Call Options Held

Put Options Held

Kingsbury Capital Investment Advisors LLC Evanston, IL

33.7K
Shares

$559,757
0.01% of portfolio
Exane Derivatives

2.65K
Shares

$44,016
0.0% of portfolio
American Portfolios Advisors Holbrook, NY

2.31K
Shares

$38,402
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About Corbus Pharmaceuticals Holdings, Inc.

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $2.08B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

More about CRBP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account